JP5008660B2 - 一体形ステント再位置決め及び回収ループ - Google Patents
一体形ステント再位置決め及び回収ループ Download PDFInfo
- Publication number
- JP5008660B2 JP5008660B2 JP2008511381A JP2008511381A JP5008660B2 JP 5008660 B2 JP5008660 B2 JP 5008660B2 JP 2008511381 A JP2008511381 A JP 2008511381A JP 2008511381 A JP2008511381 A JP 2008511381A JP 5008660 B2 JP5008660 B2 JP 5008660B2
- Authority
- JP
- Japan
- Prior art keywords
- stent
- wire
- loop
- retrieval
- wires
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000463 material Substances 0.000 claims description 45
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 34
- 229910001000 nickel titanium Inorganic materials 0.000 claims description 27
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 claims description 27
- 238000000034 method Methods 0.000 claims description 26
- 238000009954 braiding Methods 0.000 claims description 19
- 229910052697 platinum Inorganic materials 0.000 claims description 17
- -1 polypropylene Polymers 0.000 claims description 15
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 14
- 239000010931 gold Substances 0.000 claims description 14
- 229910052737 gold Inorganic materials 0.000 claims description 14
- 229920001296 polysiloxane Polymers 0.000 claims description 13
- 229910052715 tantalum Inorganic materials 0.000 claims description 13
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 claims description 13
- 239000002131 composite material Substances 0.000 claims description 11
- 239000010935 stainless steel Substances 0.000 claims description 10
- 229910001220 stainless steel Inorganic materials 0.000 claims description 10
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims description 8
- 239000010936 titanium Substances 0.000 claims description 8
- 229910052719 titanium Inorganic materials 0.000 claims description 8
- 238000005452 bending Methods 0.000 claims description 7
- 238000003466 welding Methods 0.000 claims description 7
- 229910000531 Co alloy Inorganic materials 0.000 claims description 6
- 229910052741 iridium Inorganic materials 0.000 claims description 6
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 claims description 6
- 239000007769 metal material Substances 0.000 claims description 6
- 229910052758 niobium Inorganic materials 0.000 claims description 6
- 239000010955 niobium Substances 0.000 claims description 6
- GUCVJGMIXFAOAE-UHFFFAOYSA-N niobium atom Chemical compound [Nb] GUCVJGMIXFAOAE-UHFFFAOYSA-N 0.000 claims description 6
- 239000004698 Polyethylene Substances 0.000 claims description 5
- 229920000573 polyethylene Polymers 0.000 claims description 5
- 239000002861 polymer material Substances 0.000 claims description 5
- 239000004743 Polypropylene Substances 0.000 claims description 4
- 229920000295 expanded polytetrafluoroethylene Polymers 0.000 claims description 4
- 229920000728 polyester Polymers 0.000 claims description 4
- 229920000417 polynaphthalene Polymers 0.000 claims description 4
- 229920001155 polypropylene Polymers 0.000 claims description 4
- 229920001343 polytetrafluoroethylene Polymers 0.000 claims description 4
- 239000004810 polytetrafluoroethylene Substances 0.000 claims description 4
- 229920002635 polyurethane Polymers 0.000 claims description 4
- 239000004814 polyurethane Substances 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 238000011084 recovery Methods 0.000 claims description 2
- 229920000642 polymer Polymers 0.000 description 13
- 239000011248 coating agent Substances 0.000 description 12
- 238000000576 coating method Methods 0.000 description 12
- 230000008602 contraction Effects 0.000 description 7
- 229910052751 metal Inorganic materials 0.000 description 7
- 239000003112 inhibitor Substances 0.000 description 5
- 239000002184 metal Substances 0.000 description 5
- 229920001244 Poly(D,L-lactide) Polymers 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 239000003146 anticoagulant agent Substances 0.000 description 4
- 239000003102 growth factor Substances 0.000 description 4
- 229920001432 poly(L-lactide) Polymers 0.000 description 4
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000002093 peripheral effect Effects 0.000 description 3
- 229920001610 polycaprolactone Polymers 0.000 description 3
- 239000004632 polycaprolactone Substances 0.000 description 3
- 239000012781 shape memory material Substances 0.000 description 3
- 210000005166 vasculature Anatomy 0.000 description 3
- 238000004804 winding Methods 0.000 description 3
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 2
- 229940123011 Growth factor receptor antagonist Drugs 0.000 description 2
- 229920000331 Polyhydroxybutyrate Polymers 0.000 description 2
- 229960001138 acetylsalicylic acid Drugs 0.000 description 2
- 230000000702 anti-platelet effect Effects 0.000 description 2
- 230000001028 anti-proliverative effect Effects 0.000 description 2
- 239000004019 antithrombin Substances 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000001588 bifunctional effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000000621 bronchi Anatomy 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 231100000599 cytotoxic agent Toxicity 0.000 description 2
- 239000002619 cytotoxin Substances 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229910000701 elgiloys (Co-Cr-Ni Alloy) Inorganic materials 0.000 description 2
- 210000003238 esophagus Anatomy 0.000 description 2
- 229960002897 heparin Drugs 0.000 description 2
- 229920000669 heparin Polymers 0.000 description 2
- 238000009940 knitting Methods 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920001245 poly(D,L-lactide-co-caprolactone) Polymers 0.000 description 2
- 239000005015 poly(hydroxybutyrate) Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 229910001285 shape-memory alloy Inorganic materials 0.000 description 2
- 210000003437 trachea Anatomy 0.000 description 2
- 210000005167 vascular cell Anatomy 0.000 description 2
- IHAIQFIIVUZFHC-IPIKRLCPSA-N (2s)-2-amino-3-phenylpropanoic acid;(2s)-pyrrolidine-2-carboxylic acid Chemical compound OC(=O)[C@@H]1CCCN1.OC(=O)[C@@H](N)CC1=CC=CC=C1 IHAIQFIIVUZFHC-IPIKRLCPSA-N 0.000 description 1
- PUDHBTGHUJUUFI-SCTWWAJVSA-N (4r,7s,10s,13r,16s,19r)-10-(4-aminobutyl)-n-[(2s,3r)-1-amino-3-hydroxy-1-oxobutan-2-yl]-19-[[(2r)-2-amino-3-naphthalen-2-ylpropanoyl]amino]-16-[(4-hydroxyphenyl)methyl]-13-(1h-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-p Chemical compound C([C@H]1C(=O)N[C@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(N[C@@H](CSSC[C@@H](C(=O)N1)NC(=O)[C@H](N)CC=1C=C2C=CC=CC2=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(N)=O)=O)C(C)C)C1=CC=C(O)C=C1 PUDHBTGHUJUUFI-SCTWWAJVSA-N 0.000 description 1
- ZKMNUMMKYBVTFN-HNNXBMFYSA-N (S)-ropivacaine Chemical compound CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C ZKMNUMMKYBVTFN-HNNXBMFYSA-N 0.000 description 1
- LEBVLXFERQHONN-UHFFFAOYSA-N 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide Chemical compound CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C LEBVLXFERQHONN-UHFFFAOYSA-N 0.000 description 1
- VNDNKFJKUBLYQB-UHFFFAOYSA-N 2-(4-amino-6-chloro-5-oxohexyl)guanidine Chemical compound ClCC(=O)C(N)CCCN=C(N)N VNDNKFJKUBLYQB-UHFFFAOYSA-N 0.000 description 1
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 1
- 102400000068 Angiostatin Human genes 0.000 description 1
- 108010079709 Angiostatins Proteins 0.000 description 1
- IYMAXBFPHPZYIK-BQBZGAKWSA-N Arg-Gly-Asp Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O IYMAXBFPHPZYIK-BQBZGAKWSA-N 0.000 description 1
- VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- OMFXVFTZEKFJBZ-UHFFFAOYSA-N Corticosterone Natural products O=C1CCC2(C)C3C(O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 OMFXVFTZEKFJBZ-UHFFFAOYSA-N 0.000 description 1
- 102400001047 Endostatin Human genes 0.000 description 1
- 108010079505 Endostatins Proteins 0.000 description 1
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 1
- 102000007625 Hirudins Human genes 0.000 description 1
- 108010007267 Hirudins Proteins 0.000 description 1
- UETNIIAIRMUTSM-UHFFFAOYSA-N Jacareubin Natural products CC1(C)OC2=CC3Oc4c(O)c(O)ccc4C(=O)C3C(=C2C=C1)O UETNIIAIRMUTSM-UHFFFAOYSA-N 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 229930012538 Paclitaxel Natural products 0.000 description 1
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 1
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 1
- JXLYSJRDGCGARV-WWYNWVTFSA-N Vinblastine Natural products O=C(O[C@H]1[C@](O)(C(=O)OC)[C@@H]2N(C)c3c(cc(c(OC)c3)[C@]3(C(=O)OC)c4[nH]c5c(c4CCN4C[C@](O)(CC)C[C@H](C3)C4)cccc5)[C@@]32[C@H]2[C@@]1(CC)C=CCN2CC3)C JXLYSJRDGCGARV-WWYNWVTFSA-N 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 229940035674 anesthetics Drugs 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 229960004676 antithrombotic agent Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 108010072041 arginyl-glycyl-aspartic acid Proteins 0.000 description 1
- FZCSTZYAHCUGEM-UHFFFAOYSA-N aspergillomarasmine B Natural products OC(=O)CNC(C(O)=O)CNC(C(O)=O)CC(O)=O FZCSTZYAHCUGEM-UHFFFAOYSA-N 0.000 description 1
- 229910001566 austenite Inorganic materials 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 210000003445 biliary tract Anatomy 0.000 description 1
- 239000012867 bioactive agent Substances 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 229910052797 bismuth Inorganic materials 0.000 description 1
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 229960004436 budesonide Drugs 0.000 description 1
- 229960003150 bupivacaine Drugs 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000005229 chemical vapour deposition Methods 0.000 description 1
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 1
- 229960004316 cisplatin Drugs 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 210000001953 common bile duct Anatomy 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- OMFXVFTZEKFJBZ-HJTSIMOOSA-N corticosterone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@H](CC4)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OMFXVFTZEKFJBZ-HJTSIMOOSA-N 0.000 description 1
- 238000002788 crimping Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229930013356 epothilone Natural products 0.000 description 1
- HESCAJZNRMSMJG-KKQRBIROSA-N epothilone A Chemical class C/C([C@@H]1C[C@@H]2O[C@@H]2CCC[C@@H]([C@@H]([C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)O1)O)C)=C\C1=CSC(C)=N1 HESCAJZNRMSMJG-KKQRBIROSA-N 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229960002949 fluorouracil Drugs 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 239000003966 growth inhibitor Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000002628 heparin derivative Substances 0.000 description 1
- WQPDUTSPKFMPDP-OUMQNGNKSA-N hirudin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(OS(O)(=O)=O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2)=O)CSSC1)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)CSSC1)C(C)C)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 WQPDUTSPKFMPDP-OUMQNGNKSA-N 0.000 description 1
- 229940006607 hirudin Drugs 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 108010021336 lanreotide Proteins 0.000 description 1
- 229960002437 lanreotide Drugs 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 229910000734 martensite Inorganic materials 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- KBOPZPXVLCULAV-UHFFFAOYSA-N mesalamine Chemical compound NC1=CC=C(O)C(C(O)=O)=C1 KBOPZPXVLCULAV-UHFFFAOYSA-N 0.000 description 1
- 229960004963 mesalazine Drugs 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229960001592 paclitaxel Drugs 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229920006209 poly(L-lactide-co-D,L-lactide) Polymers 0.000 description 1
- 229920006210 poly(glycolide-co-caprolactone) Polymers 0.000 description 1
- 229920002463 poly(p-dioxanone) polymer Polymers 0.000 description 1
- 239000000622 polydioxanone Substances 0.000 description 1
- 229920002643 polyglutamic acid Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 229960005205 prednisolone Drugs 0.000 description 1
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000002089 prostaglandin antagonist Substances 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 229940044551 receptor antagonist Drugs 0.000 description 1
- 239000002464 receptor antagonist Substances 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 229960001549 ropivacaine Drugs 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- NCEXYHBECQHGNR-QZQOTICOSA-N sulfasalazine Chemical compound C1=C(O)C(C(=O)O)=CC(\N=N\C=2C=CC(=CC=2)S(=O)(=O)NC=2N=CC=CC=2)=C1 NCEXYHBECQHGNR-QZQOTICOSA-N 0.000 description 1
- 229960001940 sulfasalazine Drugs 0.000 description 1
- NCEXYHBECQHGNR-UHFFFAOYSA-N sulfasalazine Natural products C1=C(O)C(C(=O)O)=CC(N=NC=2C=CC(=CC=2)S(=O)(=O)NC=2N=CC=CC=2)=C1 NCEXYHBECQHGNR-UHFFFAOYSA-N 0.000 description 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 1
- 239000003803 thymidine kinase inhibitor Substances 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 230000037426 transcriptional repression Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 229960005356 urokinase Drugs 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 229960003048 vinblastine Drugs 0.000 description 1
- JXLYSJRDGCGARV-XQKSVPLYSA-N vincaleukoblastine Chemical compound C([C@@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 JXLYSJRDGCGARV-XQKSVPLYSA-N 0.000 description 1
- 229960004528 vincristine Drugs 0.000 description 1
- OGWKCGZFUXNPDA-XQKSVPLYSA-N vincristine Chemical compound C([N@]1C[C@@H](C[C@]2(C(=O)OC)C=3C(=CC4=C([C@]56[C@H]([C@@]([C@H](OC(C)=O)[C@]7(CC)C=CCN([C@H]67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)C[C@@](C1)(O)CC)CC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-XQKSVPLYSA-N 0.000 description 1
- OGWKCGZFUXNPDA-UHFFFAOYSA-N vincristine Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(OC(C)=O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-UHFFFAOYSA-N 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/844—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents folded prior to deployment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F2002/9528—Instruments specially adapted for placement or removal of stents or stent-grafts for retrieval of stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F2002/9534—Instruments specially adapted for placement or removal of stents or stent-grafts for repositioning of stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0014—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0004—Rounded shapes, e.g. with rounded corners
- A61F2230/0013—Horseshoe-shaped, e.g. crescent-shaped, C-shaped, U-shaped
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0063—Three-dimensional shapes
- A61F2230/0069—Three-dimensional shapes cylindrical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0039—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in diameter
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Prostheses (AREA)
Description
Claims (39)
- ステントであって、
互いに反対側に位置する第1の開口端と第2の開口端を備えた管状ステントを形成するよう編成されている少なくとも2本の細長いワイヤを有し、前記第1の開口端は、第1の周囲を有し、前記第2の開口端は、第2の周囲を有し、
前記少なくとも2本のワイヤは、再位置決め及び/又は回収ループを有するように形成され、前記再位置決め及び/又は回収ループは、前記第1の開口端のところに周方向に設けられた細長い部分を有し、
前記再位置決め及び/又は回収ループの細長い部分は、前記少なくとも2本のワイヤのうちの第1のワイヤで形成され且つ前記第1の開口端の第1の周囲を実質的に横切る第1のワイヤループと、前記少なくとも2本のワイヤのうちの第2のワイヤで形成され且つ前記第1の周囲を部分的に横切る第2のワイヤループとを有し、
前記第1のワイヤループの周方向に設けられた第1の部分の一部と、前記第2のワイヤループの周方向に設けられた第2の部分とが、並んで配置される、ステント。 - 編成された前記少なくとも2本のワイヤは、編組されている、請求項1記載のステント。
- 前記第1のワイヤループの周方向に設けられた前記第1の部分のところの前記第1のワイヤは、前記第2のワイヤループの周方向に設けられた前記第2の部分のところの前記第2のワイヤを跨いでいる、請求項1記載のステント。
- 前記第1のワイヤループの周方向に設けられた前記第1の部分のところの前記第1のワイヤは、前記第2のワイヤループの周方向部分のところの前記第2のワイヤに取り付けられる、請求項1記載のステント。
- 前記ワイヤは、生体適合性金属材料及び/又はポリマー材料を含む、請求項1記載のステント。
- 前記金属材料は、ニチノール、コバルト系合金、ステンレス鋼、白金、金、チタン、タンタル、ニオブ、ポリマー材料及びこれらの組み合わせから成る群から選択される、請求項5記載のステント。
- 前記ワイヤは、ニチノールを含む、請求項6記載のステント。
- 前記ワイヤは、放射線不透過性を向上させるための複合ワイヤである、請求項5記載のステント。
- 前記ワイヤは、タンタル、金、白金、イリジウム又はこれらの組み合わせの内側コアと、ニチノールの外側部分とを有する、請求項8記載のステント。
- 編組ステントであって、
複数本のワイヤを有し、前記ワイヤは、第1のワイヤ端部及び第2のワイヤ端部を有し、前記複数のワイヤは、互いに反対側に位置する無傷性の第1のステント開口端及び第2のステント開口端を備えた管状ステントを形成するよう編組パターンで相互に編組され、前記第1のステント開口端は、第1の周囲を有し、前記第2のステント開口端は、第2の周囲を有し、
前記第1のワイヤ端部及び前記第2のワイヤ端部は、前記第2のステント開口端のところに位置し、前記ワイヤは、前記第1のワイヤ端部及び前記第2のワイヤ端部のどちらもが前記第2のステント開口端の周囲のところで露出することがないように、前記第2のステント開口端のところでループ状になっており、
前記複数本のワイヤのうちの少なくとも2本は、再位置決め及び/又は回収ループを有するように形成され、前記再位置決め及び/又は回収ループは、前記第1のステント開口端のところに周方向に設けられた細長い部分を有し、
前記再位置決め及び/又は回収ループは、第1の部分と第2の部分を有し、前記第1の部分は、前記少なくとも2本のワイヤのうちの第1のワイヤで形成され且つ前記第1の周囲を実質的に横切る第1のワイヤループを含み、前記第2の部分は、前記少なくとも2本のワイヤのうちの前記第1のワイヤと異なる第2のワイヤで形成され且つ前記第1の周囲を部分的に横切る第2のワイヤループを含み、前記第2のワイヤループの周方向に設けられた部分は、前記第1のワイヤループの周方向に設けられた部分の一部と並んで配置され、それにより医療技師が前記第1の部分と前記第2の部分の両方を同時に掴むことができ、前記第1の部分及び前記第2の部分は並んで配置された後で交差し、
前記複数のワイヤは、前記第2のワイヤを除いて、前記第1のステント開口端のところに山形曲がり部を有し、前記山形曲がり部は、無傷性の第1のステント開口端を形成するための前記編組パターンの開始部分を構成し、
前記第1のワイヤループの周方向に設けられた部分のところの第1のワイヤは、前記第1のステント開口端の前記山形曲がり部のうちの少なくとも1つを跨ぐ、編組ステント。 - 前記第2のワイヤループは、前記ステントの相互編組部分から長手方向に延びる2つの脚部を有する、請求項10記載のステント。
- 前記脚部は、基部及び頂点を有し、前記基部は、前記ステントの相互編組部分と一体であり、前記第2のワイヤは、前記第2のワイヤループの周方向に設けられた部分を形成するような前記頂点のところで山形に曲げられる、請求項11記載のステント。
- 前記第1のワイヤループの周方向に設けられた部分のところの前記第1のワイヤは、前記第2のワイヤループの周方向に設けられた部分のところの前記第2のワイヤを跨いでいる、請求項10記載のステント。
- 前記第1のワイヤループの周方向に設けられた部分のところの前記第1のワイヤは、前記第2のワイヤループの周方向に設けられた部分のところの前記第2のワイヤに取り付けられる、請求項10記載のステント。
- 前記ワイヤは、生体適合性金属材料及び/又はポリマー材料を含む、請求項10記載のステント。
- 前記第1のワイヤループの周方向に設けられた部分のところの前記第1のワイヤは、前記第1のステント端部のところの山形曲がり部のうちの少なくとも1つに取り付けられている、請求項10記載のステント。
- 前記金属材料は、ニチノール、コバルト系合金、ステンレス鋼、白金、金、チタン、タンタル、ニオブ、ポリマー材料及びこれらの組み合わせから成る群から選択される、請求項15記載のステント。
- 前記ワイヤは、ニチノールを含む、請求項17記載のステント。
- 前記ワイヤは、放射線不透過性を向上させるための複合ワイヤである、請求項10記載のステント。
- 前記ワイヤは、タンタル、金、白金、イリジウム又はこれらの組み合わせの内側コアと、ニチノールの外側部分とを有する、請求項19記載のステント。
- 前記ステントは、約10本〜約36本の偶数本のワイヤを有する、請求項10記載のステント。
- 前記ステントの内面又は外面に被せられた中空管状覆いを更に有する、請求項10記載のステント。
- 前記管状覆いは、途切れていない覆いである、請求項22記載のステント。
- 前記管状覆いは、前記ステントを実質的に覆っている、請求項22記載のステント。
- 前記管状覆いは、前記ステントの部分部分を部分的に覆っている、請求項22記載のステント。
- 前記管状覆いは、前記再位置決め及び/又は回収ループの部分部分を除き、前記ステントを実質的に覆っている、請求項22記載のステント。
- 前記管状覆いは、ポリマー材料である、請求項22記載のステント。
- 前記ポリマー材料は、ポリエステル、ポリプロピレン、ポリエチレン、ポリウレタン、ポリナフタレン、ポリテトラフルオロエチレン、発泡ポリテトラフルオロエチレン、シリコーン及びこれらの組み合わせから成る群から選択される、請求項27記載のステント。
- 互いに反対側に位置する第1のステント端部と第2のステント端部を有すると共に前記第1のステント端部のところに一体形再位置決め及び/又は回収ループを有し、前記第1のステント端部は第1の周囲を有する管状編組ステントを製造する方法であって、
互いに反対側の端部を備えた複数本の細長い生体適合性ワイヤを選択するステップと、
再位置決め及び/又は回収ループを前記複数本のワイヤのうちの少なくとも2本から形成するステップと、を有し、
前記再位置決め及び/又は回収ループは、第1の部分と第2の部分を有し、前記第1の部分は、前記少なくとも2本のワイヤのうちの第1のワイヤで形成され且つ前記第1の周囲を実質的に横切る第1のワイヤループを含み、前記第2の部分は、前記少なくとも2本のワイヤのうちの前記第1のワイヤと異なる第2のワイヤで形成され且つ前記第1の周囲を部分的に横切る第2のワイヤループを含み、前記第2のワイヤループの周方向に設けられた部分は、前記第1のワイヤループの周方向に設けられた部分の一部と並んで配置され、それにより医療技師が前記第1の部分と前記第2の部分の両方を同時に掴むことができ、前記第1の部分及び前記第2の部分は並んで配置された後で交差し、
更に、前記ワイヤを編組して前記ステントを形成するステップを有する、方法。 - 前記再位置決め及び/又は回収ループを形成する前記ステップは、編組に先立って、前記第2のワイヤを山形に曲げて2つの長手方向脚部を形成するステップを含む、請求項29記載の方法。
- 前記ワイヤを編組する前記ステップは、前記ワイヤを前記互いに反対側のワイヤ端部が前記ステントの前記第2のステント端部のところで終端するよう編組するステップを更に含む、請求項29記載の方法。
- 前記ワイヤを前記第2のステント端部のところで曲げて前記第2のステント端部のところにワイヤループを形成するステップを更に有する、請求項31記載の方法。
- 前記ワイヤ端部を互いに溶接して前記ワイヤ端部のところに閉じられたワイヤループを形成するステップを更に有する、請求項32記載の方法。
- 前記ワイヤ端部は、前記閉じられたワイヤループの一部の近位側で互いに溶接される、請求項33記載の方法。
- 前記ワイヤ端部は、近位側に配置されるが前記閉じられたワイヤループ端部の前に配置された溶接編組ワイヤ部分である、請求項34記載の方法。
- ワイヤを選択する前記ステップは、偶数本のワイヤを選択するステップを更に含む、請求項29記載の方法。
- 前記偶数のワイヤ本数は、約10本〜約36本である、請求項36記載の方法。
- 前記ステントの前記第1のステント端部のところの前記ワイヤは、前記編組ステップに先立って山形に曲げられ、その結果、前記ステントの前記第1のステント端部のところにワイヤ端部が位置することがないようになっている、請求項29記載の方法。
- 前記ステントの前記第1のステント端部のところの前記ワイヤは、前記編組ステップに先立ってワイヤ曲がり部を形成するよう山形に曲げられ、その結果、前記ステントの前記第1のステント端部のところにワイヤ端部が位置することがないようになっており、前記第1の部分を形成する前記第1のワイヤは、前記ワイヤ曲がり部のうちの少なくとも1つを跨いでいる、請求項29記載の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68068905P | 2005-05-13 | 2005-05-13 | |
US60/680,689 | 2005-05-13 | ||
PCT/US2006/018337 WO2006124541A2 (en) | 2005-05-13 | 2006-05-11 | Integrated stent repositioning and retrieval loop |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2008545453A JP2008545453A (ja) | 2008-12-18 |
JP2008545453A5 JP2008545453A5 (ja) | 2009-06-25 |
JP5008660B2 true JP5008660B2 (ja) | 2012-08-22 |
Family
ID=37000029
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008511381A Active JP5008660B2 (ja) | 2005-05-13 | 2006-05-11 | 一体形ステント再位置決め及び回収ループ |
Country Status (5)
Country | Link |
---|---|
US (6) | US9265634B2 (ja) |
EP (3) | EP2666508B1 (ja) |
JP (1) | JP5008660B2 (ja) |
ES (1) | ES2671416T3 (ja) |
WO (1) | WO2006124541A2 (ja) |
Families Citing this family (115)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7018401B1 (en) | 1999-02-01 | 2006-03-28 | Board Of Regents, The University Of Texas System | Woven intravascular devices and methods for making the same and apparatus for delivery of the same |
US20080300314A1 (en) * | 2003-11-21 | 2008-12-04 | Givaudan Sa | Cooling Compounds |
US20060206200A1 (en) * | 2004-05-25 | 2006-09-14 | Chestnut Medical Technologies, Inc. | Flexible vascular occluding device |
WO2006053270A2 (en) * | 2004-11-10 | 2006-05-18 | Boston Scientific Limited | Atraumatic stent with reduced deployment force, method for making the same and method and apparatus for deploying and positioning the stent |
DE102005003632A1 (de) | 2005-01-20 | 2006-08-17 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Katheter für die transvaskuläre Implantation von Herzklappenprothesen |
AU2006208015B2 (en) * | 2005-01-28 | 2009-12-03 | Boston Scientific Limited | Stent retrieval member and devices and methods for retrieving or repositioning a stent |
EP2666508B1 (en) * | 2005-05-13 | 2019-07-24 | Boston Scientific Limited | Integrated stent repositioning and retrieval loop |
EP1988851A2 (en) * | 2006-02-14 | 2008-11-12 | Sadra Medical, Inc. | Systems and methods for delivering a medical implant |
US8535368B2 (en) | 2006-05-19 | 2013-09-17 | Boston Scientific Scimed, Inc. | Apparatus for loading and delivering a stent |
WO2008047369A2 (en) * | 2006-10-18 | 2008-04-24 | Inspiremd Ltd. | Knitted stent jackets |
EP2083766B1 (en) | 2006-10-22 | 2016-01-27 | IDEV Technologies, INC. | Methods for securing strand ends and the resulting devices |
US7896915B2 (en) | 2007-04-13 | 2011-03-01 | Jenavalve Technology, Inc. | Medical device for treating a heart valve insufficiency |
US8187284B2 (en) * | 2007-04-23 | 2012-05-29 | Boston Scientific Scimed, Inc. | Intraluminary stent relocating apparatus |
US9034007B2 (en) | 2007-09-21 | 2015-05-19 | Insera Therapeutics, Inc. | Distal embolic protection devices with a variable thickness microguidewire and methods for their use |
US9393137B2 (en) | 2007-09-24 | 2016-07-19 | Boston Scientific Scimed, Inc. | Method for loading a stent into a delivery system |
CZ303081B6 (cs) * | 2007-12-13 | 2012-03-21 | Ella-Cs, S. R. O. | Zpusob výroby samoexpanzního biodegradabilního stentu |
US8623071B2 (en) | 2008-01-07 | 2014-01-07 | DePuy Synthes Products, LLC | Radiopaque super-elastic intravascular stent |
BR112012021347A2 (pt) | 2008-02-26 | 2019-09-24 | Jenavalve Tecnology Inc | stent para posicionamento e ancoragem de uma prótese valvular em um local de implantação no coração de um paciente |
US9044318B2 (en) | 2008-02-26 | 2015-06-02 | Jenavalve Technology Gmbh | Stent for the positioning and anchoring of a valvular prosthesis |
AT506842B1 (de) * | 2008-06-12 | 2010-03-15 | Michaela Dr Abrahamowicz | Gerät zur diagnostik eines inneren rektum-prolapses sowie einer beckenboden-senkung und zur bestimmung der douglas-tiefe |
DE102008002641A1 (de) * | 2008-06-25 | 2009-12-31 | Biotronik Vi Patent Ag | Faserstrang und implantierbarer Stützkörper mit einem Faserstrang |
DE102008033170A1 (de) | 2008-07-15 | 2010-01-21 | Acandis Gmbh & Co. Kg | Implantat mit einer geflochtenen Gitterstruktur und Verfahren zum Herstellen eines derartigen Implantats |
DE102008036429A1 (de) | 2008-08-05 | 2010-02-11 | Acandis Gmbh & Co. Kg | Medizinisches Implantat |
AU2010210404A1 (en) * | 2009-02-09 | 2011-08-25 | St. Jude Medical, Cardiology Division, Inc. | Inflatable minimally invasive system for delivering and securing an annular implant |
GB0903250D0 (en) * | 2009-02-26 | 2009-04-08 | Depuy Int Ltd | Support structure implant for a bone cavity |
KR20100119068A (ko) * | 2009-04-30 | 2010-11-09 | (주) 태웅메디칼 | 스텐트 제거용 당김줄의 걸고리 구조 |
EP2448522A4 (en) * | 2009-07-02 | 2018-01-31 | The Cleveland Clinic Foundation | Apparatus and method for replacing a diseased cardiac valve |
US8784473B2 (en) * | 2009-09-10 | 2014-07-22 | Boston Scientific Scimed, Inc. | Endoprosthesis with filament repositioning or retrieval member and guard structure |
EP3081196B1 (en) * | 2009-09-21 | 2018-04-18 | Boston Scientific Scimed, Inc. | Integrated stent retrieval loop adapted for snare removal and/or optimized purse stringing |
EP2485689B1 (en) | 2009-10-09 | 2020-03-18 | Boston Scientific Scimed, Inc. | Stomach bypass |
KR101109708B1 (ko) * | 2009-10-27 | 2012-01-31 | (주) 태웅메디칼 | 전립선 요도 확장용 스텐트 |
US9271854B2 (en) | 2010-01-29 | 2016-03-01 | Cook Medical Technologies Llc | Collapsing structure for reducing the diameter of a stent end |
US8632582B2 (en) | 2010-03-25 | 2014-01-21 | Mayo Foundation For Medical Education And Research | Removable and/or retrievable stents and kits |
EP2563290B1 (en) * | 2010-04-30 | 2020-09-02 | Boston Scientific Scimed, Inc. | Apparatus and method for manufacturing a single wire stent |
KR101160646B1 (ko) * | 2010-05-14 | 2012-06-29 | 신경민 | 위 절제 후 음식물 의한 부작용 방지 전용 스텐트 |
JP2013526388A (ja) | 2010-05-25 | 2013-06-24 | イエナバルブ テクノロジー インク | 人工心臓弁、及び人工心臓弁とステントを備える経カテーテル搬送体内プロテーゼ |
JP5801037B2 (ja) * | 2010-05-25 | 2015-10-28 | アクセスポイント テクノロジーズ有限会社 | ステント |
US9084681B2 (en) * | 2010-06-18 | 2015-07-21 | DePuy Synthes Products, Inc. | Spine disc replacement with compliant articulating core |
DE102010027123A1 (de) * | 2010-07-14 | 2012-01-19 | Acandis Gmbh & Co. Kg | Medizinische Vorrichtung |
JP6055163B2 (ja) * | 2010-07-27 | 2016-12-27 | アクセスポイント テクノロジーズ有限会社 | ステント |
DE102010044746A1 (de) * | 2010-09-08 | 2012-03-08 | Phenox Gmbh | Implantat zur Beeinflussung des Blutflusses bei arteriovenösen Fehlbildungen |
US8945207B2 (en) | 2010-12-20 | 2015-02-03 | Graftcraft I Göteborg Ab | Removable stent and method of production |
WO2012084007A1 (en) | 2010-12-20 | 2012-06-28 | Graftcraft I Göteborg Ab | Removable stent and method of production |
JP2013019347A (ja) * | 2011-07-12 | 2013-01-31 | Nihon Glassfiber Industrial Co Ltd | 金属線圧縮体 |
US9839541B2 (en) | 2011-08-22 | 2017-12-12 | Cook Medical Technologies Llc | Reconstrainable stent system |
US10441406B2 (en) * | 2012-04-06 | 2019-10-15 | Boston Scientific Scimed, Inc. | Anti-migration micropatterned stent coating |
US8882828B2 (en) * | 2012-04-27 | 2014-11-11 | Medtronic Vascular, Inc. | Ring on a closed web stent-graft for use in tip capture |
US9993582B2 (en) | 2012-09-12 | 2018-06-12 | Boston Scientific Scimed, Inc. | Adhesive stent coating for anti-migration |
CA2870173C (en) | 2012-10-25 | 2017-11-28 | Boston Scientific Scimed, Inc. | Stent having a tacky silicone coating to prevent stent migration |
WO2014134348A1 (en) * | 2013-02-28 | 2014-09-04 | Boston Scientific Scimed, Inc. | Stent with balloon for repair of anastomosis surgery leaks |
US20140257362A1 (en) * | 2013-03-07 | 2014-09-11 | St. Jude Medical, Cardiology Division, Inc. | Filtering and removing particulates from bloodstream |
US9265635B2 (en) | 2013-03-14 | 2016-02-23 | Boston Scientific Scimed, Inc. | Stent having removable anchoring element |
CN116172656A (zh) | 2013-03-15 | 2023-05-30 | 伊瑟拉医疗公司 | 脉管治疗装置和方法 |
CA2892269C (en) * | 2013-03-15 | 2021-05-25 | Merit Medical Systems, Inc. | Esophageal stent |
US8715315B1 (en) | 2013-03-15 | 2014-05-06 | Insera Therapeutics, Inc. | Vascular treatment systems |
US8715314B1 (en) | 2013-03-15 | 2014-05-06 | Insera Therapeutics, Inc. | Vascular treatment measurement methods |
US8679150B1 (en) | 2013-03-15 | 2014-03-25 | Insera Therapeutics, Inc. | Shape-set textile structure based mechanical thrombectomy methods |
WO2017142874A2 (en) | 2016-02-16 | 2017-08-24 | Insera Therapeutics, Inc. | Aspiration devices and anchored flow diverting devices |
WO2015020676A1 (en) | 2013-08-08 | 2015-02-12 | Boston Scientific Scimed, Inc. | Dissolvable or degradable adhesive polymer to prevent stent migration |
JP6563394B2 (ja) | 2013-08-30 | 2019-08-21 | イェーナヴァルヴ テクノロジー インコーポレイテッド | 人工弁のための径方向に折り畳み自在のフレーム及び当該フレームを製造するための方法 |
US9642944B2 (en) | 2014-03-17 | 2017-05-09 | Boston Scientific Scimed, Inc. | Platelet-activated bioadhesive stent coating as an antimigration mechanism |
JP6336619B2 (ja) * | 2014-06-18 | 2018-06-06 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | 胆管ステント |
KR102047167B1 (ko) * | 2015-01-16 | 2019-11-20 | 보스톤 싸이엔티픽 싸이메드 인코포레이티드 | 감소된 이동 능력을 갖는 이식가능한 의료 장치 |
KR101696810B1 (ko) * | 2015-02-04 | 2017-02-01 | 주식회사 엠아이텍 | 연결용 스텐트 및 그의 제조방법 |
EP3270825B1 (en) | 2015-03-20 | 2020-04-22 | JenaValve Technology, Inc. | Heart valve prosthesis delivery system |
KR101728319B1 (ko) * | 2015-04-15 | 2017-04-19 | 주식회사 엠아이텍 | 스텐트 제조방법 |
EP3288495B1 (en) | 2015-05-01 | 2019-09-25 | JenaValve Technology, Inc. | Device with reduced pacemaker rate in heart valve replacement |
BR102015011376B1 (pt) | 2015-05-18 | 2023-04-04 | Murilo Pundek Rocha | Brônquio artificial implantável |
JP6581292B2 (ja) * | 2015-08-17 | 2019-09-25 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | 放射性ステント |
USD784267S1 (en) * | 2015-08-17 | 2017-04-18 | Tessco Communications Incorporated | Cable braiding and strain relief |
US10004617B2 (en) | 2015-10-20 | 2018-06-26 | Cook Medical Technologies Llc | Woven stent device and manufacturing method |
US10426592B2 (en) | 2016-04-11 | 2019-10-01 | Boston Scientific Scimed, Inc. | Implantable medical device with reduced migration capabilities |
US10390944B2 (en) * | 2016-04-13 | 2019-08-27 | Hlt, Inc. | Braided support structure |
US10568754B2 (en) | 2016-05-13 | 2020-02-25 | Boston Scientific Scimed, Inc. | Protective apparatus for use in gastrointestinal tract |
EP3454795B1 (en) | 2016-05-13 | 2023-01-11 | JenaValve Technology, Inc. | Heart valve prosthesis delivery system for delivery of heart valve prosthesis with introducer sheath and loading system |
US10470904B2 (en) | 2016-05-18 | 2019-11-12 | Boston Scientific Scimed, Inc. | Stent retrieval system |
WO2018052844A1 (en) * | 2016-09-19 | 2018-03-22 | Boston Scientific Scimed, Inc. | System, device and method for treatment of endometriosis |
DE102016013721A1 (de) * | 2016-11-17 | 2018-05-17 | Grammer Ag | Feder, Verwendung eines Kunststoffschlauchs als Feder und Ausstattungsteil eines Fahrzeuginnenraums |
JP7094965B2 (ja) | 2017-01-27 | 2022-07-04 | イエナバルブ テクノロジー インク | 心臓弁模倣 |
JP6989698B2 (ja) * | 2017-10-25 | 2022-01-05 | ボストン サイエンティフィック サイムド, インコーポレイテッドBoston Scientific Scimed, Inc. | 非外傷性スペーサを備えたステント |
IL309901A (en) * | 2017-12-06 | 2024-03-01 | Butterfly Medical Ltd | A urological implant with an extraction handle and/or with a convex structure |
US20190254804A1 (en) | 2018-02-20 | 2019-08-22 | Boston Scientific Scimed, Inc. | Drainage device |
US12076226B2 (en) | 2018-03-19 | 2024-09-03 | Butterfly Medical Ltd. | Urological implant having extraction handle and/or arched members |
ES2725273B2 (es) * | 2018-03-20 | 2020-01-23 | Univ Zaragoza | Protesis intraluminal extraible, apta para el tratamiento de la traqueomalacia |
ES2941526T3 (es) * | 2018-03-20 | 2023-05-23 | Nat Res Council Canada | Un método para liofilizar cepas vacunales vivas de Francisella tularensis |
WO2019195860A2 (en) | 2018-04-04 | 2019-10-10 | Vdyne, Llc | Devices and methods for anchoring transcatheter heart valve |
DE102018207575A1 (de) | 2018-05-16 | 2019-11-21 | Kardion Gmbh | Magnetische Stirndreh-Kupplung zur Übertragung von Drehmomenten |
DE102018208541A1 (de) | 2018-05-30 | 2019-12-05 | Kardion Gmbh | Axialpumpe für ein Herzunterstützungssystem und Verfahren zum Herstellen einer Axialpumpe für ein Herzunterstützungssystem |
KR20230152842A (ko) * | 2018-06-04 | 2023-11-03 | 보스톤 싸이엔티픽 싸이메드 인코포레이티드 | 제거 가능한 스텐트 |
WO2020049734A1 (ja) * | 2018-09-07 | 2020-03-12 | オリンパス株式会社 | ステント |
US10321995B1 (en) | 2018-09-20 | 2019-06-18 | Vdyne, Llc | Orthogonally delivered transcatheter heart valve replacement |
US11344413B2 (en) | 2018-09-20 | 2022-05-31 | Vdyne, Inc. | Transcatheter deliverable prosthetic heart valves and methods of delivery |
US11071627B2 (en) | 2018-10-18 | 2021-07-27 | Vdyne, Inc. | Orthogonally delivered transcatheter heart valve frame for valve in valve prosthesis |
US11278437B2 (en) | 2018-12-08 | 2022-03-22 | Vdyne, Inc. | Compression capable annular frames for side delivery of transcatheter heart valve replacement |
WO2020068477A1 (en) | 2018-09-24 | 2020-04-02 | Boston Scientific Scimed, Inc. | Repositionable and removable stents |
US11109969B2 (en) * | 2018-10-22 | 2021-09-07 | Vdyne, Inc. | Guidewire delivery of transcatheter heart valve |
JP2022509934A (ja) * | 2018-11-16 | 2022-01-25 | マイクロベンション インコーポレイテッド | 放射線不透過性血管プロテーゼ |
WO2020106675A1 (en) * | 2018-11-19 | 2020-05-28 | Pulmair Medical, Inc. | Implantable artificial bronchus |
JP7494444B2 (ja) * | 2018-12-14 | 2024-06-04 | 住友ベークライト株式会社 | アンカーステント |
US11253359B2 (en) | 2018-12-20 | 2022-02-22 | Vdyne, Inc. | Proximal tab for side-delivered transcatheter heart valves and methods of delivery |
US11185409B2 (en) | 2019-01-26 | 2021-11-30 | Vdyne, Inc. | Collapsible inner flow control component for side-delivered transcatheter heart valve prosthesis |
US11273032B2 (en) | 2019-01-26 | 2022-03-15 | Vdyne, Inc. | Collapsible inner flow control component for side-deliverable transcatheter heart valve prosthesis |
CN113543750A (zh) | 2019-03-05 | 2021-10-22 | 维迪内股份有限公司 | 用于正交经导管心脏瓣膜假体的三尖瓣反流控制装置 |
US11076956B2 (en) | 2019-03-14 | 2021-08-03 | Vdyne, Inc. | Proximal, distal, and anterior anchoring tabs for side-delivered transcatheter mitral valve prosthesis |
US11173027B2 (en) | 2019-03-14 | 2021-11-16 | Vdyne, Inc. | Side-deliverable transcatheter prosthetic valves and methods for delivering and anchoring the same |
WO2020222364A1 (ko) * | 2019-04-29 | 2020-11-05 | 주식회사 에스앤지바이오텍 | 스텐트를 제거하기 위한 당김 부재와 루프를 포함하는 제거 가능한 스텐트 |
CN114072106A (zh) | 2019-05-04 | 2022-02-18 | 维迪内股份有限公司 | 用于在自体瓣环中部署侧面递送的假体心脏瓣膜的束紧装置和方法 |
US11419741B2 (en) | 2019-06-17 | 2022-08-23 | Boston Scientific Scimed, Inc. | Covered endoprosthesis with improved branch access |
AU2020334080A1 (en) | 2019-08-20 | 2022-03-24 | Vdyne, Inc. | Delivery and retrieval devices and methods for side-deliverable transcatheter prosthetic valves |
JP2022545728A (ja) | 2019-08-26 | 2022-10-28 | ブイダイン,インコーポレイテッド | 側方送達可能な経カテーテル人工弁ならびにそれらを送達及び固定するための方法 |
USD902407S1 (en) * | 2019-11-19 | 2020-11-17 | Pulmair Medical, Inc. | Implantable artificial bronchus |
US11234813B2 (en) | 2020-01-17 | 2022-02-01 | Vdyne, Inc. | Ventricular stability elements for side-deliverable prosthetic heart valves and methods of delivery |
USD954953S1 (en) | 2020-11-03 | 2022-06-14 | Pulmair Medical, Inc. | Implantable artificial bronchus |
CN112618105B (zh) * | 2020-12-31 | 2024-04-12 | 上海翰凌医疗器械有限公司 | 一种瓣膜支架、具有瓣膜支架与输送机构的配合装置 |
USD1014758S1 (en) | 2023-04-19 | 2024-02-13 | Pulmair Medical, Inc. | Implantable artificial bronchus |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4503569A (en) | 1983-03-03 | 1985-03-12 | Dotter Charles T | Transluminally placed expandable graft prosthesis |
US4580568A (en) | 1984-10-01 | 1986-04-08 | Cook, Incorporated | Percutaneous endovascular stent and method for insertion thereof |
ES8705239A1 (es) | 1984-12-05 | 1987-05-01 | Medinvent Sa | Un dispositivo para implantar,mediante insercion en un lugarde dificil acceso, una protesis sustancialmente tubular y radialmente expandible |
US4733665C2 (en) * | 1985-11-07 | 2002-01-29 | Expandable Grafts Partnership | Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft |
US4886062A (en) * | 1987-10-19 | 1989-12-12 | Medtronic, Inc. | Intravascular radially expandable stent and method of implant |
US4856561A (en) | 1987-11-10 | 1989-08-15 | Hydro Conduit Corporation | Seal construction for bell and spigot pipe |
US4856516A (en) * | 1989-01-09 | 1989-08-15 | Cordis Corporation | Endovascular stent apparatus and method |
EP0466412B1 (en) | 1990-07-09 | 1995-03-29 | Wilson-Cook Medical Inc. | Device for retrieving stents |
US7101392B2 (en) | 1992-03-31 | 2006-09-05 | Boston Scientific Corporation | Tubular medical endoprostheses |
EP0633798B1 (en) * | 1992-03-31 | 2003-05-07 | Boston Scientific Corporation | Vascular filter |
ATE247435T1 (de) | 1992-05-08 | 2003-09-15 | Schneider Usa Inc | Stent für den oesophagus |
US6336938B1 (en) * | 1992-08-06 | 2002-01-08 | William Cook Europe A/S | Implantable self expanding prosthetic device |
RU2089131C1 (ru) * | 1993-12-28 | 1997-09-10 | Сергей Апполонович Пульнев | Стент |
US6340367B1 (en) * | 1997-08-01 | 2002-01-22 | Boston Scientific Scimed, Inc. | Radiopaque markers and methods of using the same |
US6174330B1 (en) | 1997-08-01 | 2001-01-16 | Schneider (Usa) Inc | Bioabsorbable marker having radiopaque constituents |
US6264689B1 (en) * | 1998-03-31 | 2001-07-24 | Scimed Life Systems, Incorporated | Low profile medical stent |
US6656218B1 (en) * | 1998-07-24 | 2003-12-02 | Micrus Corporation | Intravascular flow modifier and reinforcement device |
US7018401B1 (en) | 1999-02-01 | 2006-03-28 | Board Of Regents, The University Of Texas System | Woven intravascular devices and methods for making the same and apparatus for delivery of the same |
US6398803B1 (en) * | 1999-02-02 | 2002-06-04 | Impra, Inc., A Subsidiary Of C.R. Bard, Inc. | Partial encapsulation of stents |
US20020143387A1 (en) * | 2001-03-27 | 2002-10-03 | Soetikno Roy M. | Stent repositioning and removal |
DE10118944B4 (de) | 2001-04-18 | 2013-01-31 | Merit Medical Systems, Inc. | Entfernbare, im wesentlichen zylindrische Implantate |
US6676692B2 (en) * | 2001-04-27 | 2004-01-13 | Intek Technology L.L.C. | Apparatus for delivering, repositioning and/or retrieving self-expanding stents |
US6821291B2 (en) * | 2001-06-01 | 2004-11-23 | Ams Research Corporation | Retrievable stent and method of use thereof |
US7001425B2 (en) * | 2002-11-15 | 2006-02-21 | Scimed Life Systems, Inc. | Braided stent method for its manufacture |
US20040225349A1 (en) * | 2003-05-09 | 2004-11-11 | Thistle Robert C. | Eversible locking mechanism for modular stents |
ATE504272T1 (de) * | 2003-05-23 | 2011-04-15 | Boston Scient Ltd | Stents mit angebrachten schlaufen |
US7993387B2 (en) * | 2004-05-14 | 2011-08-09 | Boston Scientific Scimed, Inc. | Stent with reduced weld profiles and a closed-end wire configuration |
US8337543B2 (en) * | 2004-11-05 | 2012-12-25 | Boston Scientific Scimed, Inc. | Prosthesis anchoring and deploying device |
WO2006053270A2 (en) * | 2004-11-10 | 2006-05-18 | Boston Scientific Limited | Atraumatic stent with reduced deployment force, method for making the same and method and apparatus for deploying and positioning the stent |
EP2666508B1 (en) * | 2005-05-13 | 2019-07-24 | Boston Scientific Limited | Integrated stent repositioning and retrieval loop |
-
2006
- 2006-05-11 EP EP13180768.7A patent/EP2666508B1/en active Active
- 2006-05-11 WO PCT/US2006/018337 patent/WO2006124541A2/en active Application Filing
- 2006-05-11 EP EP06759623.9A patent/EP1887974B1/en active Active
- 2006-05-11 ES ES06759623.9T patent/ES2671416T3/es active Active
- 2006-05-11 JP JP2008511381A patent/JP5008660B2/ja active Active
- 2006-05-11 US US11/432,065 patent/US9265634B2/en active Active
- 2006-05-11 EP EP19185559.2A patent/EP3597256B1/en active Active
-
2016
- 2016-01-18 US US14/997,984 patent/US10111766B2/en active Active
- 2016-02-26 US US15/055,527 patent/US10149776B2/en active Active
-
2018
- 2018-10-03 US US16/150,885 patent/US11013624B2/en active Active
-
2021
- 2021-05-03 US US17/306,082 patent/US11786386B2/en active Active
-
2023
- 2023-09-06 US US18/462,185 patent/US20230404782A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US10149776B2 (en) | 2018-12-11 |
JP2008545453A (ja) | 2008-12-18 |
EP3597256A1 (en) | 2020-01-22 |
EP3597256B1 (en) | 2023-01-18 |
US20160175125A1 (en) | 2016-06-23 |
WO2006124541A3 (en) | 2009-03-05 |
US10111766B2 (en) | 2018-10-30 |
US20210251784A1 (en) | 2021-08-19 |
WO2006124541A2 (en) | 2006-11-23 |
US9265634B2 (en) | 2016-02-23 |
US20060276887A1 (en) | 2006-12-07 |
US20160128853A1 (en) | 2016-05-12 |
US20190029851A1 (en) | 2019-01-31 |
EP1887974A2 (en) | 2008-02-20 |
US20230404782A1 (en) | 2023-12-21 |
ES2671416T3 (es) | 2018-06-06 |
EP2666508B1 (en) | 2019-07-24 |
EP1887974B1 (en) | 2018-04-25 |
US11013624B2 (en) | 2021-05-25 |
US11786386B2 (en) | 2023-10-17 |
EP2666508A1 (en) | 2013-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11786386B2 (en) | Integrated stent repositioning and retrieval loop | |
US11583421B2 (en) | Stent retrieval system | |
US10265203B2 (en) | Stent retrieval member and devices and methods for retrieving or repositioning a stent | |
CA2585284C (en) | Atraumatic stent with reduced deployment force, method for making the same and method and apparatus for deploying and positioning the stent | |
US20080009934A1 (en) | Endoprosthesis delivery system with stent holder |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090511 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20090511 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110620 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20110620 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20110920 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20110928 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20111018 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20120501 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20120529 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 Ref document number: 5008660 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20150608 Year of fee payment: 3 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
R371 | Transfer withdrawn |
Free format text: JAPANESE INTERMEDIATE CODE: R371 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |